|
ZNF473 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.99570385059656E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6251444634463E-12 |
| Normal-vs-Stage2 |
1.220630E-03 |
| Normal-vs-Stage3 |
4.883800E-03 |
| Normal-vs-Stage4 |
6.771600E-02 |
| Stage1-vs-Stage2 |
2.576300E-02 |
| Stage1-vs-Stage3 |
1.77845000000065E-05 |
| Stage1-vs-Stage4 |
5.7713000001236E-07 |
| Stage2-vs-Stage3 |
3.083800E-01 |
| Stage2-vs-Stage4 |
1.142380E-01 |
| Stage3-vs-Stage4 |
4.839600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.25329779677008E-11 |
| Normal-vs-AfricanAmerican |
5.047600E-02 |
| Normal-vs-Asian |
1.645720E-02 |
| Caucasian-vs-AfricanAmerican |
9.790100E-02 |
| Caucasian-vs-Asian |
8.809900E-02 |
| AfricanAmerican-vs-Asian |
4.013900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34219999559093E-08 |
| Normal-vs-Female |
1.99799954359037E-10 |
| Male-vs-Female |
9.868300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.004000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.83459980119505E-10 |
| Normal-vs-Age(61-80Yrs) |
3.75810005337485E-09 |
| Normal-vs-Age(81-100Yrs) |
1.862840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.350200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.125200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.204400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.813200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.140800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.708000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.216780E-03 |
| Normal-vs-Grade 2 |
8.88178419700125E-16 |
| Normal-vs-Grade 3 |
3.98360000000153E-05 |
| Normal-vs-Grade 4 |
2.364000E-01 |
| Grade 1-vs-Grade 2 |
2.259000E-01 |
| Grade 1-vs-Grade 3 |
1.038450E-02 |
| Grade 1-vs-Grade 4 |
4.373700E-04 |
| Grade 2-vs-Grade 3 |
6.04339999999981E-05 |
| Grade 2-vs-Grade 4 |
4.56460000020087E-07 |
| Grade 3-vs-Grade 4 |
5.409700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
1.043950E-03 |
| ccA subtype-vs-ccB subtype |
1.10240000461559E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.98710000360359E-08 |
| Normal-vs-N1 |
9.087000E-01 |
| N0-vs-N1 |
6.753900E-02 |
|
|
